These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1808248)

  • 21. [Cytokines on hemodialysis].
    Yamagami S
    Nihon Rinsho; 1992 Jan; 50 Suppl():643-50. PubMed ID: 1578748
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood purification for patients with chronic renal failure accompanied by severe liver disease].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():66-9. PubMed ID: 15250270
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of acetate and bicarbonate on the tolerance for hemodialysis therapy in chronic kidney failure].
    Shostka GD; T'iagi S; Kulikova AI; Spiridonov VN; Kostkina MI; Vitenberg AG
    Urol Nefrol (Mosk); 1990; (6):39-44. PubMed ID: 2089765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity reactions related to acetate dialyzate and cellulose acetate membrane.
    Caravaca F; Pizarro JL; Arrobas M; Cubero JJ; Antona JM; Sanchez E
    Nephron; 1987; 45(2):158-9. PubMed ID: 3561625
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetate metabolism, organic acid production, and the independent effects of bicarbonate and acetate as alkalinizing agents in dialysis bath solutions.
    Gennari FJ; Sargent JA
    Semin Dial; 2019 May; 32(3):274-275. PubMed ID: 31006902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correction of the acid-base equilibrium in patients with chronic renal insufficiency during hemodialysis].
    Levandovskaia GI; Torgunakov AP; Astudin VP
    Urol Nefrol (Mosk); 1974; (1):20-2. PubMed ID: 4446132
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of dialyzer material and dialysate composition on hypoxemia during hemodialysis].
    Igarashi H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 May; 24(5):531-40. PubMed ID: 3761768
    [No Abstract]   [Full Text] [Related]  

  • 30. [The course of chronic kidney failure during acetate and bicarbonate hemodialysis].
    Shostka GD; T'iagi S
    Ter Arkh; 1991; 63(8):89-93. PubMed ID: 1792628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR monitoring of the energy status of skeletal muscle during hemodialysis using acetate.
    Cardoso M; Shoubridge E; Arnold D; Léveillé M; Prud'Homme M; St-Louis G; Vinay P
    Clin Invest Med; 1988 Aug; 11(4):292-6. PubMed ID: 3168351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P; Faict D; Verberckmoes R
    Ann Biol Clin (Paris); 1985; 43(3):267-9. PubMed ID: 3927790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 36. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D; Knoll G
    Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The launching of bicarbonate dialysis in Pilsen].
    Veselá E; Köcher P; Racek J; Opatrný K
    Cas Lek Cesk; 1986 Apr; 125(16):491-3. PubMed ID: 3719624
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
    Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
    Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent flushing in a hemodialysis patient.
    Georgiadou F; Moutzouris DA; Kassimatis TI; Charitaki E; Christodoulidou C; Margelos V; Hadjiconstantinou V
    Semin Dial; 2006; 19(6):558-9. PubMed ID: 17150061
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
    Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.